Search research articles
Contact Us
Filters
Showing results (51-60 of 84) with videos related to
Page
of 9
Sort By:
ACS Chemical Biology
|
May 25, 2022
Directed Evolution of PD-L1-Targeted Affibodies by mRNA Display
Brian J Grindel, Brian J Engel, Justin N Ong, et al.
Journal for Immunotherapy of Cancer
|
October 4, 2023
PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity
Paul Koller, Natalia Baran, Karine Harutyunyan, et al.
Journal for Immunotherapy of Cancer
|
August 3, 2021
High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege
Casey R Ager, Akash Boda, Kimal Rajapakshe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 1, 2002
Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells
Mary A Price, Scott S Case, Denise A Carbonaro, et al.
The Journal of Clinical Investigation
|
September 7, 2018
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
Priyamvada Jayaprakash, Midan Ai, Arthur Liu, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 22, 2012
Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer model
Yohei Mineharu, A K M Ghulam Muhammad, Kader Yagiz, et al.
Neuro-Oncology
|
January 27, 2023
Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human disease
Chao-Hsien Chen, Renee L Chin, Genevieve P Hartley, et al.
Science Translational Medicine
|
October 26, 2018
Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma
Liran Zhou, Hongmei Husted, Todd Moore, et al.
Clinical and Molecular Hepatology
|
July 22, 2024
Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial
Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, et al.
Clinical and Molecular Hepatology
|
February 27, 2025
Erratum to 'Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial' [Clin Mol Hepatol 2024;30:807-823]
Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 84) with videos related to
Sort By:
Page
of 9
ACS Chemical Biology
|
May 25, 2022
Directed Evolution of PD-L1-Targeted Affibodies by mRNA Display
Brian J Grindel, Brian J Engel, Justin N Ong, et al.
Journal for Immunotherapy of Cancer
|
October 4, 2023
PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity
Paul Koller, Natalia Baran, Karine Harutyunyan, et al.
Journal for Immunotherapy of Cancer
|
August 3, 2021
High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege
Casey R Ager, Akash Boda, Kimal Rajapakshe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 1, 2002
Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells
Mary A Price, Scott S Case, Denise A Carbonaro, et al.
The Journal of Clinical Investigation
|
September 7, 2018
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
Priyamvada Jayaprakash, Midan Ai, Arthur Liu, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 22, 2012
Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer model
Yohei Mineharu, A K M Ghulam Muhammad, Kader Yagiz, et al.
Neuro-Oncology
|
January 27, 2023
Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human disease
Chao-Hsien Chen, Renee L Chin, Genevieve P Hartley, et al.
Science Translational Medicine
|
October 26, 2018
Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma
Liran Zhou, Hongmei Husted, Todd Moore, et al.
Clinical and Molecular Hepatology
|
July 22, 2024
Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial
Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, et al.
Clinical and Molecular Hepatology
|
February 27, 2025
Erratum to 'Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial' [Clin Mol Hepatol 2024;30:807-823]
Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, et al.
Page
of 9